Literature DB >> 28498183

Impact of Facility- and Community-Based Peer Support Models on Maternal Uptake and Retention in Malawi's Option B+ HIV Prevention of Mother-to-Child Transmission Program: A 3-Arm Cluster Randomized Controlled Trial (PURE Malawi).

Sam Phiri1, Hannock Tweya, Monique van Lettow, Nora E Rosenberg, Clement Trapence, Atupele Kapito-Tembo, Blessings Kaunda-Khangamwa, Florence Kasende, Virginia Kayoyo, Fabian Cataldo, Christopher Stanley, Salem Gugsa, Veena Sampathkumar, Erik Schouten, Levison Chiwaula, Michael Eliya, Frank Chimbwandira, Mina C Hosseinipour.   

Abstract

BACKGROUND: Many sub-Saharan African countries have adopted Option B+, a prevention of mother-to-child transmission approach providing HIV-infected pregnant and lactating women with immediate lifelong antiretroviral therapy. High maternal attrition has been observed in Option B+. Peer-based support may improve retention.
METHODS: A 3-arm stratified cluster randomized controlled trial was conducted in Malawi to assess whether facility- and community-based peer support would improve Option B+ uptake and retention compared with standard of care (SOC). In SOC, no enhancements were made (control). In facility-based and community-based models, peers provided patient education, support groups, and patient tracing. Uptake was defined as attending a second scheduled follow-up visit. Retention was defined as being alive and in-care at 2 years without defaulting. Attrition was defined as death, default, or stopping antiretroviral therapy. Generalized estimating equations were used to estimate risk differences (RDs) in uptake. Cox proportional hazards regression with shared frailties was used to estimate hazard of attrition.
RESULTS: Twenty-one facilities were randomized and enrolled 1269 women: 447, 428, and 394 in facilities that implemented SOC, facility-based, and community-based peer support models, respectively. Mean age was 27 years. Uptake was higher in facility-based (86%; RD: 6%, confidence interval [CI]: -3% to 15%) and community-based (90%; RD: 9%, CI: 1% to 18%) models compared with SOC (81%). At 24 months, retention was higher in facility-based (80%; RD: 13%, CI: 1% to 26%) and community-based (83%; RD: 16%, CI: 3% to 30%) models compared with SOC (66%).
CONCLUSIONS: Facility- and community-based peer support interventions can benefit maternal uptake and retention in Option B+.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28498183     DOI: 10.1097/QAI.0000000000001357

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr        ISSN: 1525-4135            Impact factor:   3.731


  33 in total

1.  Assessing Option B+ retention and infant follow-up in Lilongwe, Malawi.

Authors:  Blake M Hauser; William C Miller; Hannock Tweya; Colin Speight; Tiwonge Mtande; Sam Phiri; L M Ball; Mina C Hosseinipour; Irving F Hoffman; Nora E Rosenberg
Journal:  Int J STD AIDS       Date:  2017-07-27       Impact factor: 1.359

2.  Taking Malawi's option B+ programme from a B+ to an A.

Authors:  Nora E Rosenberg; Audrey E Pettifor
Journal:  Lancet HIV       Date:  2018-11-19       Impact factor: 12.767

3.  Viral Suppression and HIV Drug Resistance at 6 Months Among Women in Malawi's Option B+ Program: Results From the PURE Malawi Study.

Authors:  Mina Hosseinipour; Julie A E Nelson; Clement Trapence; Sarah E Rutstein; Florence Kasende; Virginia Kayoyo; Blessings Kaunda-Khangamwa; Kara Compliment; Christopher Stanley; Fabian Cataldo; Monique van Lettow; Nora E Rosenberg; Hannock Tweya; Salem Gugsa; Veena Sampathkumar; Erik Schouten; Michael Eliya; Frank Chimbwandira; Levison Chiwaula; Atupele Kapito-Tembo; Sam Phiri
Journal:  J Acquir Immune Defic Syndr       Date:  2017-06-01       Impact factor: 3.731

4.  Retention in HIV Care During Pregnancy and the Postpartum Period in the Option B+ Era: Systematic Review and Meta-Analysis of Studies in Africa.

Authors:  Brandon A Knettel; Cody Cichowitz; James Samwel Ngocho; Elizabeth T Knippler; Lilian N Chumba; Blandina T Mmbaga; Melissa H Watt
Journal:  J Acquir Immune Defic Syndr       Date:  2018-04-15       Impact factor: 3.731

5.  Effects of Depression, Stigma and Intimate Partner Violence on Postpartum Women's Adherence and Engagement in HIV Care in Kenya.

Authors:  Maricianah Onono; Tobias Odwar; Lisa Abuogi; Kevin Owuor; Anna Helova; Elizabeth Bukusi; Janet Turan; Karen Hampanda
Journal:  AIDS Behav       Date:  2020-06

6.  The effect of a Mentor Mothers program on prevention of vertical transmission of HIV outcomes in Zambézia Province, Mozambique: a retrospective interrupted time series analysis.

Authors:  James G Carlucci; Zhihong Yu; Purificación González; Magdalena Bravo; Gustavo Amorim; Cristina das Felicidades Cugara; Helga Guambe; Jaime Mucanhenga; Wilson Silva; José A Tique; Maria Fernanda Sardella Alvim; Erin Graves; Caroline De Schacht; C William Wester
Journal:  J Int AIDS Soc       Date:  2022-06       Impact factor: 6.707

7.  Measuring retention in HIV care: the impact of data sources and definitions using routine data.

Authors:  Tamsin K Phillips; Catherine Orrell; Kirsty Brittain; Allison Zerbe; Elaine J Abrams; Landon Myer
Journal:  AIDS       Date:  2020-04-01       Impact factor: 4.632

8.  Baseline characteristics of study sites and women enrolled in a three-arm cluster randomized controlled trial: PMTCT uptake and retention (pure) Malawi.

Authors:  Monique van Lettow; Hannock Tweya; Nora E Rosenberg; Clement Trapence; Virginia Kayoyo; Florence Kasende; Blessings Kaunda; Mina C Hosseinipour; Michael Eliya; Fabian Cataldo; Salem Gugsa; Sam Phiri
Journal:  Reprod Health       Date:  2017-07-11       Impact factor: 3.223

9.  Improving Retention in Care Among Pregnant Women and Mothers Living With HIV: Lessons From INSPIRE and Implications for Future WHO Guidance and Monitoring.

Authors:  Nigel C Rollins; Shaffiq M Essajee; Nita Bellare; Meg Doherty; Gottfried O Hirnschall
Journal:  J Acquir Immune Defic Syndr       Date:  2017-06-01       Impact factor: 3.731

Review 10.  Improving postpartum retention in care for women living with HIV in the United States.

Authors:  Florence M Momplaisir; Deborah S Storm; Hervette Nkwihoreze; Olakunle Jayeola; John B Jemmott
Journal:  AIDS       Date:  2018-01-14       Impact factor: 4.177

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.